Cervical Ca PROs in Clinical Practice
关键词
抽象
日期
最后验证: | 03/31/2019 |
首次提交: | 02/06/2017 |
提交的预估入学人数: | 02/06/2017 |
首次发布: | 02/08/2017 |
上次提交的更新: | 04/23/2019 |
最近更新发布: | 04/24/2019 |
实际学习开始日期: | 02/26/2017 |
预计主要完成日期: | 10/31/2020 |
预计完成日期: | 10/31/2020 |
状况或疾病
干预/治疗
Other: Cervical Cancer Patients
Other: Oncologist
相
手臂组
臂 | 干预/治疗 |
---|---|
Cervical Cancer Patients Adult, English-speaking cervical cancer patients, who have been treated with curative intent chemo-radiotherapy. | Other: Cervical Cancer Patients Disease specific Patient Reported Outcome measurement tool developed by the European Organization for Research and Treatment of Cancer (EORTC). This questionnaire covers symptoms common to women with cervical cancer and captures the impact of disease and/or treatment on domains including: urologic and gastro-intestinal symptoms, sexual functioning and body image. |
Oncologist Oncologists who treat cervix cancer, with at least one consenting patient enrolled in the study. | Other: Oncologist This Feedback form to be completed by oncologists who have had at least one consenting patient participating in this study. |
资格标准
有资格学习的年龄 | 18 Years 至 18 Years |
有资格学习的性别 | All |
取样方式 | Non-Probability Sample |
接受健康志愿者 | 是 |
标准 | Patient Inclusion Criteria: 1. Adult (> 18 years) English speaking patients 2. Treated with curative intent with chemo-radiotherapy 3. Seen in routine clinic follow-up within 5 years post completion of treatment Patient Exclusion Criteria: 1. Patients at their anticipated last clinic visit prior to cancer center discharge 2. Patients unable to complete the EORTC QLQ CX-24 questionnaire due to inability to read or write. 3. Non-English speaking patients 4. Patients of the principal investigator. The rationale for this is that patients of the principal investigator who complete the Feedback form may be biased and this may be reflected in the results. Oncologist Inclusion Criteria: 1. Oncologists who treat cervix cancer 2. Oncologists with at least one consenting patient enrolled in the study Oncologist Exclusion Criteria: 1) Principal investigator listed on the protocol. The rationale for this is that oncologists who are also investigators on this study may have inherent bias in the study which may be reflected in the results of the Feedback form. |
结果
主要结果指标
1. Percentage of EORTC QLQ CX24 questionnaire completed [9 months]
2. Percentage of favorable scores (Agree or strongly agree) on Feedback Form [9 months]